Literature DB >> 6332077

Interleukin 1 production by peripheral blood mononuclear cells from leprosy patients.

S Watson, W Bullock, K Nelson, V Schauf, R Gelber, R Jacobson.   

Abstract

Quantitation of interleukin 1 production by adherent mononuclear cells from peripheral blood was performed in patients with tuberculoid and lepromatous forms of leprosy. Cells from patients with tuberculoid leprosy either secreted interleukin 1 spontaneously or produced amounts within the normal range in response to lipopolysaccharide stimulation. Conversely, stimulated cells from lepromatous patients failed to produce interleukin 1 in 5 of 13 (38.5%) cases.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6332077      PMCID: PMC263369          DOI: 10.1128/iai.45.3.787-789.1984

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  17 in total

1.  Purification and properties of human lymphocyte activating factor (LAF).

Authors:  G Blyden; R E Handschumacher
Journal:  J Immunol       Date:  1977-05       Impact factor: 5.422

2.  Studies on the purification and structure-functional relationships of murine lymphocyte activating factor (Interleukin 1).

Authors:  S B Mizel
Journal:  Mol Immunol       Date:  1980-05       Impact factor: 4.407

3.  Soluble factor activation of human B lymphocytes.

Authors:  R J Ford; S R Mehta; D Franzini; R Montagna; L B Lachman; A L Maizel
Journal:  Nature       Date:  1981-11-19       Impact factor: 49.962

Review 4.  T-T cell interactions during cytotoxic T lymphocyte (CTL) responses: T cell derived helper factor (Interleukin 2) as a probe to analyze CTL responsiveness and thymic maturation of CTL progenitors.

Authors:  H Wagner; C Hardt; K Heeg; K Pfizenmaier; W Solbach; R Bartlett; H Stockinger; M Röllinghoff
Journal:  Immunol Rev       Date:  1980       Impact factor: 12.988

5.  Classification of leprosy according to immunity. A five-group system.

Authors:  D S Ridley; W H Jopling
Journal:  Int J Lepr Other Mycobact Dis       Date:  1966 Jul-Sep

6.  Alloreactive cloned T cell lines. V. Differential kinetics of IL 2, CSF, and BCSF release by a cloned T amplifier cell and its variant.

Authors:  J M Ely; M B Prystowsky; L Eisenberg; J Quintans; E Goldwasser; A L Glasebrook; F W Fitch
Journal:  J Immunol       Date:  1981-12       Impact factor: 5.422

7.  Identification of a specific interleukin 1 inhibitor in the urine of febrile patients.

Authors:  Z Liao; R S Grimshaw; D L Rosenstreich
Journal:  J Exp Med       Date:  1984-01-01       Impact factor: 14.307

8.  Potentiation of the T-lymphocyte response to mitogens. II. The cellular source of potentiating mediator(s).

Authors:  I Gery; B H Waksman
Journal:  J Exp Med       Date:  1972-07-01       Impact factor: 14.307

9.  Release of endogenous pyrogen-activating factor from concanavalin A-stimulated human lymphocytes.

Authors:  H A Bernheim; L H Block; L Francis; E Atkins
Journal:  J Exp Med       Date:  1980-12-01       Impact factor: 14.307

10.  The functional relationship of the interleukins.

Authors:  K A Smith; L B Lachman; J J Oppenheim; M F Favata
Journal:  J Exp Med       Date:  1980-06-01       Impact factor: 14.307

View more
  10 in total

1.  Release of interleukin-1 by peripheral blood mononuclear cells in patients with tuberculosis and active inflammation.

Authors:  S W Chensue; M P Davey; D G Remick; S L Kunkel
Journal:  Infect Immun       Date:  1986-04       Impact factor: 3.441

2.  Defective production of leucocytic endogenous mediator (interleukin 1) by peripheral blood leucocytes of patients with systemic sclerosis, systemic lupus erythematosus, rheumatoid arthritis and mixed connective tissue disease.

Authors:  J T Whicher; A M Gilbert; C Westacott; C Hutton; P A Dieppe
Journal:  Clin Exp Immunol       Date:  1986-07       Impact factor: 4.330

3.  Serum levels of tumour necrosis factor-alpha and interleukin-1 beta during leprosy reactional states.

Authors:  E N Sarno; G E Grau; L M Vieira; J A Nery
Journal:  Clin Exp Immunol       Date:  1991-04       Impact factor: 4.330

4.  Mycobacterium leprae fails to stimulate phagocytic cell superoxide anion generation.

Authors:  T J Holzer; K E Nelson; R G Crispen; B R Andersen
Journal:  Infect Immun       Date:  1986-02       Impact factor: 3.441

Review 5.  Leprosy.

Authors:  R C Hastings; T P Gillis; J L Krahenbuhl; S G Franzblau
Journal:  Clin Microbiol Rev       Date:  1988-07       Impact factor: 26.132

6.  Dissociation between interleukin-1 and interleukin-2 production in proliferative response to microbial antigens: restorative effect of exogenous interleukin-2.

Authors:  D Vismara; G Lombardi; E Piccolella; V Colizzi
Journal:  Infect Immun       Date:  1985-08       Impact factor: 3.441

7.  Inappropriate responses to Mycobacterium leprae infections--C reactive protein in man and serum amyloid P in mice.

Authors:  R A Thompson; K D Sukumaran; K Rajagopalan
Journal:  Clin Exp Immunol       Date:  1985-08       Impact factor: 4.330

8.  Defective production of interleukin-6 in very small premature infants in response to bacterial pathogens.

Authors:  A Yachie; N Takano; K Ohta; T Uehara; S Fujita; T Miyawaki; N Taniguchi
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

9.  Interleukin-1 released by blood-monocyte-derived macrophages from patients with leprosy.

Authors:  P R Ridel; P Jamet; Y Robin; M A Bach
Journal:  Infect Immun       Date:  1986-04       Impact factor: 3.441

10.  Interleukin 1 in Crohn's disease.

Authors:  J Satsangi; R A Wolstencroft; J Cason; C C Ainley; D C Dumonde; R P Thompson
Journal:  Clin Exp Immunol       Date:  1987-03       Impact factor: 4.330

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.